Search Results - "Mulloy, Laura L"

Humanized Mouse Model as a Novel Approach in the Assessment of Human Allogeneic Responses in Organ Transplantation by Ajith, Ashwin, Mulloy, Laura L, Musa, Md Abu, Bravo-Egana, Valia, Horuzsko, Daniel David, Gani, Imran, Horuzsko, Anatolij

“…The outcome of organ transplantation is largely dictated by selection of a well-matched donor, which results in less chance of graft rejection. An allogeneic…”
Get full text

HLA-G Dimers in the Prolongation of Kidney Allograft Survival by Horuzsko, Anatolij, Jagadeesan, Muralidharan, Kapoor, Rajan, Horuzsko, Daniel D., Wu, Juan, Portik-Dobos, Vera, Ezeakile, Maureen, Mulloy, Laura L.

“…Human leukocyte antigen-G (HLA-G) contributes to acceptance of allografts in solid organ/tissue transplantation. Most studies have determined that soluble…”
Get full text

New onset diabetic ketoacidosis in a renal transplant recipient by Skalak, Havird McLean, Haas, Kaitlyn, Laub, Melissa, Mulloy, Laura L.

“…Post-transplant diabetes mellitus (PTDM) is a well-known solid organ transplant complication, which can be related to immunosuppressants, particularly…”
Get full text

Effects of a medication assistance program with medication therapy management on the health of renal transplant recipients by Chisholm, Marie A, Spivey, Christina A, Mulloy, Laura L

“…The effects of a medication assistance program with medication therapy management (MTM) on the clinical outcomes and health-related quality of life (HQOL) of…”
Get full text

A Randomized Trial to Reduce Disparities in Referral for Transplant Evaluation by Patzer, Rachel E, Paul, Sudeshna, Plantinga, Laura, Gander, Jennifer, Sauls, Leighann, Krisher, Jenna, Mulloy, Laura L, Gibney, Eric M, Browne, Teri, Zayas, Carlos F, McClellan, William M, Arriola, Kimberly Jacob, Pastan, Stephen O

“…Georgia has the lowest kidney transplant rates in the United States and substantial racial disparities in transplantation. We determined the effectiveness of a…”
Get full text

Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients by Chisholm, Marie A, Lance, Charles E, Mulloy, Laura L

“…Factors associated with adherence to immunosuppressant therapy (IST) in renal transplant recipients were studied. The Immunosuppressant Therapy Adherence Scale…”
Get full text

IL-10-producing memory B regulatory cells as a novel target for HLA-G to prolong human kidney allograft survival by Ajith, Ashwin, Mamouni, Kenza, Musa, Abu, Horuzsko, Daniel D., Gani, Imran, Mulloy, Laura L., Horuzsko, Anatolij

“…Despite the growing interest in the role of regulatory B cells (Bregs) in autoimmunity, their distinct role and function in kidney transplant outcomes remain…”
Get full text

Nonmodifiable characteristics associated with nonadherence to immunosuppressant therapy in renal transplant recipients by Chisholm-Burns, Marie A, Kwong, W Jaqueline, Mulloy, Laura L, Spivey, Christina A

“…Relationships between adherence to immunosuppressant therapy and adult renal transplant recipients' age, time posttransplant, race, and sex were evaluated to…”
Get full text

HLA-G and humanized mouse models as a novel therapeutic approach in transplantation by Ajith, Ashwin, Portik-Dobos, Vera, Horuzsko, Daniel D., Kapoor, Rajan, Mulloy, Laura L., Horuzsko, Anatolij

“…HLA-G is a nonclassical MHC-Class I molecule whose expression, along the feto-maternal barrier contributes towards tolerance of the semiallogeneic fetus during…”
Get full text

HLA‐G dimer targets Granzyme B pathway to prolong human renal allograft survival by Ajith, Ashwin, Portik‐Dobos, Vera, Nguyen‐Lefebvre, Anh Thu, Callaway, Christine, Horuzsko, Daniel D., Kapoor, Rajan, Zayas, Carlos, Maenaka, Katsumi, Mulloy, Laura L., Horuzsko, Anatolij

“…ABSTRACTHuman leukocyte antigen G (HLA‐G), a nonclassic HLA class Ib molecule involved in the maintenance of maternal tolerance to semiallogeneic fetal tissues…”
Get full text

Impact of clinical pharmacy services on renal transplant recipients' adherence and outcomes by Chisholm-Burns, Marie A, Spivey, Christina A, Garrett, Charlene, McGinty, Herbert, Mulloy, Laura L

“…The purpose of this article is to provide a description of a clinical pharmacy services program implemented in a renal transplant clinic to improve medication…”
Get full text

Mouse models for studies of HLA-G functions in basic science and pre-clinical research by Nguyen-Lefebvre, Anh Thu, Ajith, Ashwin, Portik-Dobos, Vera, Horuzsko, Daniel D, Mulloy, Laura L, Horuzsko, Anatolij

“…Abstract HLA-G was described originally as a tolerogenic molecule that allows the semiallogeneic fetus to escape from recognition by the maternal immune…”
Get full text

The RaDIANT community study protocol: community-based participatory research for reducing disparities in access to kidney transplantation by Patzer, Rachel E, Gander, Jennifer, Sauls, Leighann, Amamoo, M Ahinee, Krisher, Jenna, Mulloy, Laura L, Gibney, Eric, Browne, Teri, Plantinga, Laura, Pastan, Stephen O

“…The Southeastern United States has the lowest kidney transplant rates in the nation, and racial disparities in kidney transplant access are concentrated in…”
Get full text

Predicting adherence to immunosuppressant therapy: a prospective analysis of the theory of planned behaviour by Chisholm, Marie A., Williamson, Gail M., Lance, Charles E., Mulloy, Laura L.

“…Background. The objective of this study was to increase the ability to predict renal transplant patients (RTPs) who are most likely to be non-adherent to their…”
Get full text

Development and validation of the immunosuppressant therapy adherence instrument (ITAS) by Chisholm, Marie A., Lance, Charles E., Williamson, Gail M., Mulloy, Laura L.

“…A five-item scale was developed that asked respondents to indicate how often they were non-adherent to immunosuppressant therapy (IST) given a particular…”
Get full text

Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications by Chisholm, Marie A, Mulloy, Laura L, Jagadeesan, Muralidharan, DiPiro, Joseph T

“…Background: Non‐compliance with immunosuppressive medications may result in allograft rejection and is regarded as an important impediment to post‐transplant…”
Get full text

Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation by LAWEN, Joseph G, DAVIES, Elizabeth A, KORN, Alexander, GIRAULT, Danièle, MOURAD, Georges, OPPENHEIMER, Frederic, GONZALEZ MOLINA, Miguel, ROSTAING, Lionel, WILEINSON, Alan H, MULLOY, Laura L, BOURBIGOT, Bernard J, PRESTELE, Hans

“…Acute rejection remains a major problem in renal transplantation. Immunoprophylaxis with basiliximab (Simulect) has achieved significant reductions in acute…”
Get full text

Development and validation of an immunosuppressant therapy adherence barrier instrument by Chisholm, Marie A., Lance, Charles E., Williamson, Gail M., Mulloy, Laura L.

“…Background. To decrease allograft rejection as a result of non-adherence to immunosuppressant therapy (IST), a valid and reliable instrument that measures…”
Get full text

Renal transplant patient compliance with free immunosuppressive medications by CHISHOLM, Marie A, VOLLENWEIDER, Leslie J, MULLOY, Laura L, JAGADEESAN, Muralidharan, WYNN, James J, ROGERS, Holly E, WADE, William E, DIPIRO, Joseph T

“…Noncompliance with immunosuppressive medications after renal transplantation is believed to be a major cause of allograft rejection and graft loss, with the…”
Get full text

Isoforms of human leukocyte antigen-G and their inhibitory receptors in human kidney allograft acceptance by Wu, Juan, Zhang, Wei, Hernandez-Lopez, Pedro, Fabelo, Edward, Parikh, Mehul, Mulloy, Laura L, Horuzsko, Anatolij

“…Abstract Novel therapeutic strategies such as the modulation of dendritic cell and T-cell function have exhibited great potential in clinical transplantation…”
Get full text